Peng Liang

Dr. Peng Liang

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XLXiang Li
Xiang Li
ZBZhenghong Bi
Zhenghong Bi
RDRong Di
Rong Di
PLPeng Liang
Peng Liang
QHQiguang He
Qiguang He
FZFucong Zheng
Fucong Zheng
Powdery mildew is an important disease of rubber trees caused by Oidium heveae B. A. Steinmann. As far as we know, none of the resistance genes related to powdery mildew have been isolated from the rubber tree. There is little information available at the molecular level regarding how a rubber tree develops defense mechanisms against this pathogen. We have studied rubber tree mRNA transcripts from the resistant RRIC52 cultivar by differential display analysis. Leaves inoculated with the spores of O. heveae were collected from 0 to 120 hpi in order to identify pathogen-regulated genes at different infection stages. We identified 78 rubber tree genes that were differentially expressed during the plant–pathogen interaction. BLAST analysis for these 78 ESTs classified them into seven functional groups: cell wall and membrane pathways, transcription factor and regulatory proteins, transporters, signal transduction, phytoalexin biosynthesis, other metabolism functions, and unknown functions. The gene expression for eight of these genes was validated by qRT-PCR in both RRIC52 and the partially susceptible Reyan 7-33-97 cultivars, revealing the similar or differential changes of gene expressions between these two cultivars. This study has improved our overall understanding of the molecular mechanisms of rubber tree resistance to powdery mildew.

27 November 2002
Verified
Conference Paper
Closed access
XLXuemin Liu
Xuemin Liu
PLPeng Liang
Peng Liang
JLJiawei Li
Jiawei Li
YXYuru Xu
Yuru Xu

1 October 2024 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
PLPeng Liang
Peng Liang
QCQianxi Chen
Qianxi Chen
XCXiaoping Chen
Xiaoping Chen
XZXiaolin Zhang
Xiaolin Zhang
YXYizhen Xiao
Yizhen Xiao
BCBo Chen
Bo Chen
Background: While the resident microbiome of tumors has been shown to be associated with the occurrence and progression of non-small cell lung cancer, there remains a significant knowledge gap in understanding the correlation between the microbial spectrum and immunity response to cancer therapy. In the case of lung adenocarcinoma (LUAD), the tumor microenvironment, encompassing a diverse array of microbes and immune cells, plays a crucial role in modulating therapeutic response. Towards comprehending the underlying mechanism, we present the microbe-immunity interactive networks to delineate the microbiota and immunity repertoires for two distinct molecular subtypes in LUAD. Methods: We obtained multi-omics data of LUAD patients from the publicly available database. In this study, we conducted a systematic exploration of the microbial and immunological etiology of cancer prognosis, by integrating the microbiome, genome, transcriptome, and clinic data. The mutational signature analysis, transcriptome analysis, gene set enrichment analysis, and microbiota-immunity network analysis were performed. Results: Based on the transcriptome repertories, we classified the patients into two molecular subtypes and observed that the overall survival of molecular subtype 2 (MS2) was notably shortened. We identified the microbial biomarkers in patients that distinguished between these molecular subtypes. The significant up-regulation of γδT and neutrophil in MS2, suggesting the inflammation augmentation and stimulation of γδT activation. What is more, the MS2 are characterized by a correlation network between microbiota biomarkers and γδT cell, which may contribute to suppression of anti-tumor immunity and poor overall survival. Conclusions: Our findings not only display the repertoires of tumor microbiota and immune cells, but also elucidate the potential contribution of the microbiota-immunity correlation network to unfavorable overall survival and therapeutic resistance, thereby exerting profound implications on future LUAD therapy.

17 January 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XCXiaoping Chen
Xiaoping Chen
KCKehan Chen
Kehan Chen
XMXingxing Ma
Xingxing Ma
BCBo Chen
Bo Chen
PLPeng Liang
Peng Liang
QCQianxi Chen
Qianxi Chen
Background Lung cancer remains the deadliest malignancy globally. Although therapies, including immune checkpoint inhibitors and targeted therapy, have gradually prolonged overall survival, resistance and relapse still plague clinical management. Baicalein, a naturally derived compound exhibiting potent antitumor and anti-inflammatory properties, is widely regarded as a promising candidate for the development of anticancer therapeutic agents. Nevertheless, its mechanism of action in lung cancer remains unclear. Objective This study aims to elucidate the multi-target pharmacological mechanism by which Baicalein acts in lung cancer treatment, utilizing network pharmacology, immune infiltration analysis, molecular docking, and molecular dynamics simulation. Methods Using the TCMSP, Swiss Target Prediction, and Pharm Mapper databases, we identified the relevant targets of Baicalein. Meanwhile, lung cancer-associated targets were retrieved from the GeneCards database. The targets were obtained by taking the intersection of these two sets. A protein-protein interaction (PPI) network was then constructed using Cytoscape. Furthermore, the influence of these core targets to the tumor immune microenvironment was investigated via immune infiltration analysis. Finally, we employed molecular docking to evaluate the binding affinity between Baicalein and targets, followed by molecular dynamics simulations to confirm the stability of these interactions. Results A total of 92 potential targets of Baicalein for lung cancer were identified. Five core targets, including TP53, AKT1, MAPK3, BCL2, and EGFR, were determined based on the connectivity characteristics of the PPI network. These core targets were significantly enriched in the PI3K-AKT signaling pathway. Molecular dynamics simulations displayed that the binding free energy of the AKT1–baicalein complex was − 199.8 kJ/mol. Energy decomposition analysis suggested that complex stabilization is primarily driven by shape complementarity and hydrophobic effects, rather than conventional hydrogen bonding or salt bridges. Conclusion This study reveals that the antitumor activity of Baicalein is mediated through its multi-target action on core components of the PI3K-AKT pathway, thereby offering novel insights for exploring its therapeutic targets.

28 May 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YZYang Zou
Yang Zou
YLYanni Lin
Yanni Lin
CZChenglong Zhang
Chenglong Zhang
YLYang Li
Yang Li
XCXiaoping Chen
Xiaoping Chen
PLPeng Liang
Peng Liang
Introduction: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid-β (Aβ) plaques and pervasive cognitive decline. Bavachinin, a natural flavonoid derived from the traditional medicinal herb Psoralea corylifolia, has previously been demonstrated to inhibit Aβ aggregation in vitro . However, its potential to alleviate cognitive impairment, restore large-scale brain network dysfunctions, and mitigate AD-related pathology in vivo remains elusive. Methods: In this study, we systematically evaluated the therapeutic efficacy of bavachinin on AD-associated pathology, cortical slow-wave activity (SWA), and behavioral phenotypes in 5xFAD transgenic mice. We utilized behavioral assessments to evaluate learning and memory, mesoscopic wide-field calcium imaging to assess cortical network dynamics, and histological analyses to measure cerebral Aβ deposition. Furthermore, pharmacological inhibition was employed to investigate the mechanistic role of mitochondrial oxidative phosphorylation (OXPHOS). Results: Behavioral assessments revealed that bavachinin administration significantly rescued deficits in learning and memory. Mesoscopic wide-field calcium imaging further demonstrated that bavachinin substantially enhanced the synchrony of cortical SWA while reducing its frequency in 5xFAD mice, indicating a restoration of network-level dynamics. Histological analyses confirmed a marked reduction in cerebral Aβ deposition, which occurred independent of Aβ production pathways. Mechanistically, bavachinin bolstered microglial Aβ phagocytosis and chemotactic migration by promoting mitochondrial OXPHOS, thereby revitalizing cellular energy metabolism. Notably, pharmacological inhibition of OXPHOS partially abrogated the therapeutic benefits of bavachinin, suggesting that the augmentation of mitochondrial function is a requisite for its anti-AD effects. Discussion: In summary, bavachinin alleviates cognitive impairment and neuropathology in AD model mice by driving microglial metabolic reprogramming and facilitating Aβ clearance. These findings highlight its robust potential as a therapeutic candidate for AD.

28 September 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
YZYang Zou
Yang Zou
JYJun Yang
Jun Yang
YLYang Li
Yang Li
GWGuodong Wang
Guodong Wang
WLWen Lu
Wen Lu
TZTao Zhuo
Tao Zhuo
Background: Although depression is a potent risk factor for Alzheimer's disease (AD), the underlying causal mechanisms remain unclear. This study investigated the molecular and circuit‐level mechanisms linking chronic stress to accelerated AD pathogenesis and evaluated the therapeutic potential of precise mTORC1 targeting. Methods: A chronic restraint stress (CRS) paradigm was established in 5xFAD mice. Multi‐scale neurofunctional and histopathological alterations were deconstructed using behavioral profiling, wide‐field and two‐photon calcium imaging, immunofluorescence, and bulk RNA‐sequencing. Pharmacological intervention was conducted using the specific mTORC1 inhibitor EN6. Results: CRS severely impaired cortical slow‐wave oscillations and induced aberrant prefrontal single‐neuron hyperactivity, exacerbating cognitive decline. These network deficits were accompanied by accelerated AD hallmarks, including elevated Aβ deposition, dystrophic neurite aggravation, and reactive gliosis. Mechanistically, transcriptomic profiling and biochemical validation revealed that chronic stress suppresses autophagic pathways via selective hyperactivation of mTORC1 signaling rather than the AMPK pathway. Time‐course analysis showed that mTORC1 activation and autophagy‐related abnormalities preceded overt Aβ accumulation, while pharmacological mTOR activation with MHY1485 further aggravated autophagic impairment and increased Aβ42 levels. Crucially, targeted mTORC1 inhibition with EN6 ameliorated autophagy‐related abnormalities and was associated with reduced BACE1 abundance and CTFβ generation, together with a diminished global Aβ burden. This microenvironmental stabilization attenuated neuroinflammation, realigned neural networks, and rescued both cognitive and emotional deficits. Conclusion: Chronic stress‐induced mTORC1 hyperactivation is associated with autophagic impairment, contributing to macro‐circuit desynchronization and accelerated amyloid accumulation. Targeting the mTORC1–autophagy axis represents a potential therapeutic approach to mitigate neural network breakdown and neuropathology in stress‐related neurodegenerative conditions.